Altered dopamine D2 receptor function in fibromyalgia patients: A neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls

Journal of Affective Disorders

Volumn 75, Issue 1, 2003, Pages 77-82

  Malt, Eva Albertsen ^a,b,c   Olafsson, Snorri ^a,c   Aakvaag, Asbjoern ^a,c   Lund, Anders ^a,c   Ursin, Holger ^a,c  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

5 HT1A receptors; Dopamine; Dopamine D2 receptors; Fibromyalgia; Neuroendocrine challenge; Serotonin

Indexed keywords

BUSPIRONE; DOPAMINE; DOPAMINE 2 RECEPTOR; GROWTH HORMONE; PROLACTIN; SEROTONIN; SEROTONIN AGONIST;

ADULT; ANXIETY; ARTICLE; BODY TEMPERATURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE CALCULATION; FEMALE; FIBROMYALGIA; GROWTH HORMONE RELEASE; HORMONE DETERMINATION; HORMONE RESPONSE; HUMAN; HYPOTHERMIA; NEUROENDOCRINE SYSTEM; NEUROTRANSMISSION; POPULATION RESEARCH; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROVOCATION TEST; RECEPTOR BLOCKING; RECEPTOR DENSITY; RECEPTOR SENSITIVITY; STRESS; CELL COUNT; HEALTH SURVEY; MENTAL STRESS; METABOLISM; MIDDLE AGED; MOOD DISORDER; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ANXIETY; BODY TEMPERATURE; BUSPIRONE; CELL COUNT; FEMALE; FIBROMYALGIA; HUMANS; MIDDLE AGED; MOOD DISORDERS; POPULATION SURVEILLANCE; PROLACTIN; RECEPTORS, DOPAMINE D2; SEROTONIN AGONISTS; STRESS, PSYCHOLOGICAL;

EID: 0038012656     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(02)00025-3     Document Type: Article

References (29)

1. Alfici S., Sigal M., Landau M. Primary fibromyalgia syndrome - a variant of depressive disorder? Psychother. Psychosom. 51:1989;156-161.
2. Bakheit A.M., Behan P.O., Dinan T.G., Gray C.E., O'Keane V. Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. Br. Med. J. 304:1992;1010-1012.
3. Chua A., Keating J., Hamilton D., Keeling P.W., Dinan T.G. Central serotonin receptors and delayed gastric emptying in non-ulcer dyspepsia. Br. Med. J. 305:1992;280-282.
4. Cleare A.J., Forsling M., Bond A.J. Neuroendocrine and hypothermic effects of 5-HT1A receptor stimulation with ipsapirone in healthy men: a placebo-controlled study. Int. Clin. Psychopharmacol. 13:1998;23-32.
5. Cowen P.J., Anderson I.M., Grahame Smith D.G. Neuroendocrine effects of azapirones. J. Clin. Psychopharmacol. 10:1990;21S-25S.
6. Cowen P.J., Power A.C., Ware C.J., Anderson I.M. 5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone. Br. J. Psychiatry. 164:1994;372-379.
7. Dinan T.G., Barry S., Yatham L.N., Mobayed M., O'Hanlon M. The reproducibility of the prolactin response to buspirone: relationship to the menstrual cycle. Int. Clin. Psychopharmacol. 5:1990;119-123.
8. Dinan T.G., Yatham L.N., Barry S., Chua A., Keeling P.W. Serotonin supersensitivity: the pathophysiologic basis of non-ulcer dyspepsia? A preliminary report of buspirone/prolactin responses. Scand. J. Gastroenterol. 25:1990;541-544.
9. Hudson J.I., Pope H.G. Jr. Fibromyalgia and psychopathology: is fibromyalgia a form of 'affective spectrum disorder'? J. Rheumatol. Suppl. 19:1989;15-22.
10. Hudson J.I., Pope H.G. The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain. Bailliere's Clin. Rheumatol. 8:1994;839-856.
11. Hudson J.I., Goldenberg D.L., Pope H.G. Jr., Keck P.E. Jr., Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am. J. Med. 92:1992;363-367.
12. Lesch K.P., Mayer S., Disselkamp-Tietze J., Hoh A., Schoellnhammer G., Schulte H.M. Subsensitivity of the 5-hydroxytryptamine1A (5-HT1A) receptor-mediated hypothermic response to ipsapirone in unipolar depression. Life Sci. 46:1990;1271-1277.
13. MacLennan A.J., Pelleymounter M.A., Atmadja S., Jakubovic A., Maier S.F., Fibiger H.C. D2 dopamine receptors in the rat prefrontal cortex: characterization and alteration by stress. Brain Res. 477:1989;300-307.
14. Madrid G.A., MacMurray J., Lee J.W., Anderson B.A., Comings D.E. Stress as a mediating factor in the association between the DRD2 TaqI polymorphism and alcoholism. Alcohol. 23:2001;117-122.
15. Malt E.A., Berle J., Olafsson S., Lund A., Ursin H. Fibromyalgia is associated with panic disorder and functional dyspepsia with mood disorders. A study of women with random sample population controls. J. Psychosom. Res. 49:2000;285-289.
16. Maskall D.D., Zis A.P., Lam R.W., Clark C.M., Kuan A.J. Prolactin response to buspirone challenge in the presence of dopaminergic blockade. Biol. Psychiatry. 38:1995;235-239.
17. Mc Ivor R.J., Davies R.A., Wieck A., Marks M.N., Brown N., Campbell I.C., Checkley S.A., Kumar R. The growth hormone response to apomorphine at 4 days postpartum in women with a history of major depression. J. Affect. Disord. 40:1996;131-136.
18. Meltzer H.Y., Fleming R. Effect of buspirone on prolactin and growth hormone secretion in laboratory rodents and man. J. Clin. Psychiatry. 43:1982;76-79.
19. Meltzer H.Y., Lee H.S., Nash J.F. Jr. Effect of buspirone on prolactin secretion is not mediated by 5-HT-1a receptor stimulation. Arch. Gen. Psychiatry. 49:1992;163-164.
20. Neeck G. Neuroendocrine and hormonal perturbations and relations to the serotonergic system in fibromyalgia patients. Scand. J. Rheumatol. Suppl. 113:2000;8-12.
21. Noble E.P. The DRD2 gene in psychiatric and neurological disorders and its phenotypes. Pharmacogenomics. 1:2000;309-333.
22. Offenbaecher M., Bondy B., de Jonge S., Glatzeder K., Kruger M., Schoeps P., Ackenheil M. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum. 42:1999;2482-2488.
23. Peroutka S.-J. Dopamine and migraine. Neurology. 49:(3):1997;650-656.
24. Rasmussen Dennis D.A. Effects of chronic nicotine treatment and withdrawal on hypothalamic proopiomelanocortin gene expression and neuroendocrine regulation. Psychoneuroendocrinology. 23:1998;259.
25. Sharpe M., Clements A., Hawton K., Young A.H., Sargent P., Cowen P.J. Increased prolactin response to buspirone in chronic fatigue syndrome. J. Affect. Disord. 41:1996;71-76.
26. SPSS For Windows (version 9). 1999;SPSS Inc, Chicago.
27. Stratz T., Samborski W., Hrycaj P., Pap T., Mackiewicz S., Mennet P., Muller W. Serotonin concentration in serum of patients with generalized tendomyopathy (fibromyalgia) and chronic polyarthritis. Med. Klin. 88:1993;458-462.
28. Tanum L., Malt U.F. Sodium lactate infusion in fibromyalgia patients. Biol. Psychiatry. 38:1995;559-561.
29. Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L., Tugwell P., Campbell S.M. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum. 33:1990;160-172.